openPR Logo
Press release

Global Biomarkers Market Growing With 12.2% CAGR - Analysis And Industry Forecasts By 2024

10-27-2017 04:13 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

"Biomarkers Market" - Industry Trends and Forecast to 2024

"Biomarkers Market" - Industry Trends and Forecast to 2024

Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brief Sample of the Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Factors that led to growth in the Global Biomarkers Market are increase in research and development financing and in drugs discovery along with the spending more in healthcare activities. The developing use of biomarkers in medical areas (cancer treatment) and new players entrants will definitely lead to the growth of biomarkers market in future. Biomarkers are widely used to distinguish diseases such as, cancer, cardiovascular disorders, neurological disorders, immunological disorders and many others. In the field of oncology, as of late three natural markers have been added to breast cancer disease risk models to distinguish ladies at a higher danger.

Major Market Drivers and Restraints:

• Increase in R&D financing and healthcare expenditure
• Developing number of CROs
• Rising utility of biomarkers for treatment purposes
• Ease in leading clinical trials in developing countries
• High capital ventures and cost-to-profit proportions
• High cost of testing, sample collection, and storage
• Administrative and reimbursement challenges

The market is segmented on the basis of type, technology, application, indication, and geography.

Read more about the report @ databridgemarketresearch.com/reports/global-biomarkers-ma...

Based On Type:
• Consumables
• Services
• Softwares
Based on Technology:
• Efficacy
• Safety
• Validation Biomakers
Based On Application:
• Diagnostics
• Drug Discovery
• Personalized Medicine
• Disease Risk Assessment
Based On Indication:
• Cancer
• Cardiovascular Disorders
• Immunological Disorders

Based on geography the market is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

The Global Biomarkers Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are
• QIAGEN
• PerkinElmer, Inc.
• Merck & Co.
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• EKF Diagnostics Holdings Plc
• Abbott
• Siemens AG
• MESO SCALE DIAGOSTICS, LLC
• Agilent Technologies
• Singulex, Inc.
• Cisbio Bioassays
• Thermo Fisher Scientific Inc.
• Bruker
• Biosims Technologies
• Epigenomics AG
• Signosis, Inc.
• GE Healthcare

Speak to our Analyst: http:/databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biomarkers-market

Table Of Content:

1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

1.2.MARKET SEGMENTATION & COVERAGE

1.2.1.CURRENCY AND PRICING

1.2.2.LIMITATION

1.2.3.STAKEHOLDERS

2.RESEARCH METHODOLOGY

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.DATA TRIANGULATION

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.PRODUCT PIPELINE ANALYSIS

2.2.6.PORTER’S FIVE FORCES MATRIX

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET LANDSCAPE SUMMARY

4.PREMIUM INSIGHTS

4.1.OVERVIEW

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

4.3.MARKET OVERVIEW

4.3.1.DRIVERS

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

4.3.1.2.NON-INVASIVE

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

4.3.1.4.GROWING NUMBER OF CROs

4.3.2.RESTRAINTS

4.3.3.OPPURTUNITIES

4.3.4.THREATS

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.EXECUTIVE SUMMARY

6.BIOMARKERS MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.CONSUMABLES,

6.3.SERVICES,

6.4.SOFTWARE,

7.BIOMARKERS MARKET, BY TECHNOLOGY

7.1.OVERVIEW

7.2.SAFETY BIOMARKERS

7.3.EFFICACY BIOMARKERS

7.4.VALIDATION BIOMARKERS

8.BIOMARKERS MARKET, BY APPLICATION

8.1. OVERVIEW

8.2. DIAGNOSTICS DEVELOPMENT

8.3. DRUG DISCOVERY AND DEVELOPMENT

8.4. PERSONALIZED MEDICINE

8.5 DISEASE-RISK ASSESSMENT

8.6. OTHERS

9.BIOMARKERS MARKET, BY INDICATION

9.1.OVERVIEW

9.2.CANCER

9.3.CARDIOVASCULAR DISORDERS

9.4.NEUROLOGICAL DISORDERS

9.5.IMMUNOLOGICAL DISORDERS

9.6.OTHER DISEASES

10.BIOMARKERS MARKET, BY GEOGRAPHY

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1.NORTH AMERICA

10.1.1.1.U.S.

10.1.1.2.CANADA

10.1.1.3.MEXICO

10.1.2.EUROPE

10.1.2.1.GERMANY

10.1.2.2.FRANCE

10.1.2.3.U.K.

10.1.2.4.ITALY

10.1.2.5.SPAIN

10.1.2.6.RUSSIA

10.1.2.7.TURKEY

10.1.2.8.BELGIUM

10.1.2.9.NETHERLANDS

10.1.2.10.SWITZERLAND

10.1.2.11.REST OF EUROPE

10.1.3.ASIA-PACIFIC (APAC)

10.1.3.1.JAPAN

10.1.3.2.CHINA

10.1.3.3.SOUTH KOREA

10.1.3.4.INDIA

10.1.3.5.AUSTRALIA

10.1.3.6.SINGAPORE

10.1.3.7.THAILAND

10.1.3.8.MALAYSIA

10.1.3.9.INDONESIA

10.1.3.10.PHILIPPINES

10.1.3.11.REST OF APAC

10.1.4.LATIN AMERICA

10.1.4.1.BRAZIL

10.1.4.2.REST OF LATIN AMERICA

10.1.5.MIDDLE EAST AND AFRICA

10.1.5.1.SOUTH AFRICA

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.7.MERGERS & ACQUISITIONS

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

11.9.EXPANSIONS

11.10.REGULATORY CHANGES

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12.BIOMARKERS MARKET, COMPANY PROFILES

12.1.QIAGEN N.V

12.1.1.COMPANY OVERVIEW

12.1.2.SWOT ANALYSIS

12.1.3.REVENUE ANALYSIS

12.1.4.PRODUCT PORTFOLIO

12.1.5.RECENT DEVELOPEMENTS

12.1.6.DATA BRIDGE ANALYSIS

12.2.PERKINELMER, INC

12.2.1.COMPANY OVERVIEW

12.2.2.SWOT ANALYSIS

12.2.3.REVENUE ANALYSIS

12.2.4.PRODUCT PORTFOLIO

12.2.5.RECENT DEVELOPEMENTS

12.2.6.DATA BRIDGE ANALYSIS

12.3.MERCK & CO, INC.

12.3.1.COMPANY OVERVIEW

12.3.2.SWOT ANALYSIS

12.3.3.REVENUE ANALYSIS

12.3.4.PRODUCT PORTFOLIO

12.3.5.RECENT DEVELOPEMENTS

12.3.6.DATA BRIDGE ANALYSIS

12.4.BIO-RAD LABORATORIES

12.4.1.COMPANY OVERVIEW

12.4.2.SWOT ANALYSIS

12.4.3.REVENUE ANALYSIS

12.4.4.PRODUCT PORTFOLIO

12.4.5.RECENT DEVELOPEMENTS

12.4.6.DATA BRIDGE ANALYSIS

12.5.ENZO BIOCHEM, INC.,

12.5.1.COMPANY OVERVIEW

12.5.2.SWOT ANALYSIS

12.5.3.REVENUE ANALYSIS

12.5.4.PRODUCT PORTFOLIO

12.5.5.RECENT DEVELOPEMENTS

12.5.6.DATA BRIDGE ANALYSIS

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

12.6.1.COMPANY OVERVIEW

12.6.2.SWOT ANALYSIS

12.6.3.REVENUE ANALYSIS

12.6.4.PRODUCT PORTFOLIO

12.6.5.RECENT DEVELOPEMENTS

12.6.6.DATA BRIDGE ANALYSIS

12.7.MESO SCALE DIAGNOSTICS

12.7.1.COMPANY OVERVIEW

12.7.2.SWOT ANALYSIS

12.7.3.REVENUE ANALYSIS

12.7.4.PRODUCT PORTFOLIO

12.7.5.RECENT DEVELOPEMENTS

12.7.6.DATA BRIDGE ANALYSIS

12.8.LLC, SINGULEX, INC.,

12.8.1.COMPANY OVERVIEW

12.8.2.SWOT ANALYSIS

12.8.3.REVENUE ANALYSIS

12.8.4.PRODUCT PORTFOLIO

12.8.5.RECENT DEVELOPEMENTS

12.8.6.DATA BRIDGE ANALYSIS

12.9.CISBIO BIOASSAYS

12.9.1.COMPANY OVERVIEW

12.9.2.SWOT ANALYSIS

12.9.3.REVENUE ANALYSIS

12.9.4.PRODUCT PORTFOLIO

12.9.5.RECENT DEVELOPEMENTS

12.9.6.DATA BRIDGE ANALYSIS

12.10.BIOSIMS TECHNOLOGIES

12.10.1.COMPANY OVERVIEW

12.10.2.SWOT ANALYSIS

12.10.3.REVENUE ANALYSIS

12.10.4.PRODUCT PORTFOLIO

12.10.5.RECENT DEVELOPEMENTS

12.10.6.DATA BRIDGE ANALYSIS

12.11. SIGNOSIS, INC.

12.11.1.COMPANY OVERVIEW

12.11.2.SWOT ANALYSIS

12.11.3.REVENUE ANALYSIS

12.11.4.PRODUCT PORTFOLIO

12.11.5.RECENT DEVELOPEMENTS

12.11.6.DATA BRIDGE ANALYSIS

13.APPENDIX

14.ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: databridgemarketresearch.com/reports/global-drug-delivery...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biomarkers Market Growing With 12.2% CAGR - Analysis And Industry Forecasts By 2024 here

News-ID: 790941 • Views: 175

More Releases from Data Bridge Market Research

GDPR Services Market: Hitachi Systems Security, Dell, Metricstream, IBM, Veritas …
Global GDPR Services Market, By Offering Type (Solutions [Data Management, Api Management], Services [Professional Services, Managed Services]), Organization Size (Small & Medium Enterprises (SMEs), Large Enterprises), Geographical Segments (North America, South America, Europe, Asia-Pacific, Middle East And Africa) - Forecast to 2025 The Global GDPR Services Market is expected to reach USD 4271.5 million by 2025 from USD 765.2 million in 2017 and is projected to grow at a CAGR of
+14.00% CAGR of Cloud Project Portfolio Management Market Analysis by Top Key Pl …
The Cloud Project Portfolio Management Market research report is stacked up with data and significant examination of market value, natural examination late upgrades, and current examples. Accordingly, it transforms into a huge bit of leeway for the producers and financial specialists of the business. The report uncovers overall evaluation and veritable pieces of the Cloud Project Portfolio Management Market. The report shows a straightforward diagram of the Cloud Project Portfolio
Data Fabric Market Analysis by Top Key Players Denodo Technologies, Global IDs, …
This Global Data Fabric Market research report is characterized with the most superb and predominant devices of gathering, recording, assessing and looking at market data of Information and Communication Technology industry. Data Fabric Market report additionally advances with the data, factual, statistical data points focuses which are useful for the associations to boost or limit the creation of products relying upon the states of intrigue. Data Fabric Market report has
Cognitive Data Management Market Growing at a Healthy CAGR of 30.1% With Top Com …
The Cognitive Data Management Market research report gives in-detail broke down information to direct its clients in comprehension and foreseeing the development and improvement of the worldwide Cognitive Data Management Market for a particular conjecture period i.e. 2018-2025. After profound research and examination by the specialists, they likewise revealed the information about the solid contenders contributing in the Cognitive Data Management Market development and extension and testing each other

All 31845 Releases


More Releases for BIOMARKERS

Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out
Biomarkers Summit
SMi's 4th annual Biomarkers summit featuring 28 leading industry experts, provides the perfect platform to network with other industry professionals, whilst gaining invaluable up to date knowledge from leaders in the Biomarker field. On Wednesday February 2nd, we will also be hosting an interactive post-conference workshop entitled: Fit for Purpose Biomarkers: From Bench to Bedside Hosted by: Eric Culbert, Executive Consultant, BioScience Innovations. In association with: BioScience Innovations This highly interactive workshop will
Biomarkers
SMi Group is proud to announce their 4th annual Biomarkers Summit... Biomarkers Summit Biomarker Discovery, Validation and Qualification 31st January to 1st February 2011, Crowne Plaza - The City, London, United Kingdom. Sponsored by RBM Overview It is now clear that the use of biomarkers is an integral part in the future of medicine. With rising development costs and a declining rate of new drug discovery, pharmaceutical companies are now incorporating biomarker strategies into